• Journal of the Institute of Electronics and Information Engineers
• /
• v.51 no.10
• /
• pp.213-220
• /
• 2014

Korean magnetoencephalography (MEG) system had been developed and installed to hospital. The Korean MEG system contains helmet-shaped arrays of 152 first-order double relaxation oscillation SQUID (DROS) sensor. As a clinical application we have measured and analyzed evoked responses in patients with functional brain disease by outer stimulation as follows; 1) auditory evoked field in patients with hemifacial spasm, 2) somatosensory evoked fields in patients with tumor. We confirm that neuromagnetic data by Korean MEG system can provide useful information for pre-surgical planning or functional brain research.

• Journal of Life Science
• /
• v.27 no.5
• /
• pp.600-610
• /
• 2017

It was common that the classification of itching was classified into four categories according to the neurophysiological mechanisms of pruritoceptive itching, neuropathic itching, neurogenic itching and psychogenic itching. Recently it was classified by clinical criteria. The neurotransmission pathway of itch is divided into histamine-dependent pathway and histamine-independent pathway. Different receptors and neuropeptides act on each itch mediator. Itch mediators such as histamine, BAM8-22, and chloroquine are transmitted through the histamine-dependent pathway. Cowhage spicule, protease, and TSLP (Thymic stromal lymphopoietin) have been reported to be related to the histamine-independent pathway. These itch mediators, receptors, and neuropeptides are the targets of treatment for itching. Although itching and pain are typical noxious stimuli, and in the past, it was argued that two senses were transmitted through one noxious stimulus receptor. It has recently been shown that itching and pain have an independent neurotransmitter system and both neuronal systems inhibit each other. In addition, the mutual antagonism between itching and pain is explained by various mechanisms. Recently, many new mediators and receptors are being studied. The studies on histamine 4 receptor (H4 receptor) have been actively conducted. And the H4 receptors are expressed in immune cells such as T cells. The therapeutic agent for blocking the H4 receptor can inhibit the inflammatory reaction itself, which is important for the itching and chronicization. Understanding the underlying mechanisms of itching and studying new itch mediators will lead to the development of effective therapies, and this is what I think the itching study will go on.